glp-1 pancreatic cancer GLP-1s appear to cut risk. Researchers are asking why and how : NPR Ozempic and Cancer Risk: Study

Based on the latest results, orforglipron has a better profile than the only approved oral GLP-1 medication

DPP-4 inhibitors improve diabetic wound healing via direct and indirect promotion of epithelial-mesenchymal transition and reduction of scarring

Your doctor can send a new prescription to a different pharmacy, or you can ask the new pharmacy to transfer any remaining refills from your current one

Preoperative considerations of new long-acting glucagon-like peptide-1receptor agonists in diabetes mellitus

NLY01 which is a pegylated analogue of exenatide showed no improvements either with or without dopaminergic therapy